CervoMed Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
CervoMed Inc. (CRVO) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of -$5.36 million for the 12-month period ending 2013-12-31, per its 10-K/A filed 2014-04-23.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2014-04-23
- CervoMed Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2013 was -$5.36M.
- CervoMed Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2012 was -$2.13M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2013-12-31 | -$5.36M 10-K/A · filed 2014-04-23 |
| 2012-12-31 | -$2.13M 10-K/A · filed 2014-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |